Psoralen structure
|
Common Name | Psoralen | ||
---|---|---|---|---|
CAS Number | 66-97-7 | Molecular Weight | 186.163 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 362.6±27.0 °C at 760 mmHg | |
Molecular Formula | C11H6O3 | Melting Point | 160-162 °C | |
MSDS | Chinese USA | Flash Point | 173.1±23.7 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of PsoralenPsoralen(Furocoumarin) is an active ingredient from Fructus Psoraleae; has anticancer activity.IC50 value:Target:in vitro: Psoralen dosages of 1-10 μM exhibited low cytotoxicity toward chondrocytes. However, a dosage of 100 μM suppressed the proliferation of chondrocytes. Different concentrations of psoralen treatments on chondrocytes revealed that GAG and Type II collagen synthesis increased, especially at 100 μM, by 0.39-fold and 0.48-fold, respectively, on day 3, and by 0.51-fold and 0.56-fold, respectively, on day 9 [1]. in vivo: Tumor volume inhibition rates were 43.75% and 40.18%, respectively, in the psoralen and isopsoralen low-dose groups, and tumor weight inhibition rates were 38.83% and 37.77%. Tumor volume inhibition rates were 67.86% and 66.96%, respectively, in the psoralen and isopsoralen high-dose groups, and tumor weight inhibition rates were 49.47% and 47.87% [2]. psoralen can inhibit metastasis of breast cancer to bone in vivo. Histological, molecular biological, and imaging analyses revealed that psoralen inhibits bone metastases in mice [3]. |
Name | psoralen |
---|---|
Synonym | More Synonyms |
Description | Psoralen(Furocoumarin) is an active ingredient from Fructus Psoraleae; has anticancer activity.IC50 value:Target:in vitro: Psoralen dosages of 1-10 μM exhibited low cytotoxicity toward chondrocytes. However, a dosage of 100 μM suppressed the proliferation of chondrocytes. Different concentrations of psoralen treatments on chondrocytes revealed that GAG and Type II collagen synthesis increased, especially at 100 μM, by 0.39-fold and 0.48-fold, respectively, on day 3, and by 0.51-fold and 0.56-fold, respectively, on day 9 [1]. in vivo: Tumor volume inhibition rates were 43.75% and 40.18%, respectively, in the psoralen and isopsoralen low-dose groups, and tumor weight inhibition rates were 38.83% and 37.77%. Tumor volume inhibition rates were 67.86% and 66.96%, respectively, in the psoralen and isopsoralen high-dose groups, and tumor weight inhibition rates were 49.47% and 47.87% [2]. psoralen can inhibit metastasis of breast cancer to bone in vivo. Histological, molecular biological, and imaging analyses revealed that psoralen inhibits bone metastases in mice [3]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 362.6±27.0 °C at 760 mmHg |
Melting Point | 160-162 °C |
Molecular Formula | C11H6O3 |
Molecular Weight | 186.163 |
Flash Point | 173.1±23.7 °C |
Exact Mass | 186.031693 |
PSA | 43.35000 |
LogP | 1.67 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.667 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | LV0944000 |
Precursor 9 | |
---|---|
DownStream 4 | |
Rotavirus increases levels of lipidated LC3 supporting accumulation of infectious progeny virus without inducing autophagosome formation.
PLoS ONE 9(4) , e95197, (2014) Replication of many RNA viruses benefits from subversion of the autophagic pathway through many different mechanisms. Rotavirus, the main etiologic agent of pediatric gastroenteritis worldwide, has be... |
|
Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance.
Drug Metab. Dispos. 43(1) , 34-41, (2014) The mechanistic understanding of interactions between diet-derived substances and conventional medications in humans is nascent. Most investigations have examined cytochrome P450-mediated interactions... |
|
Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.
J. Pharmacol. Exp. Ther. 351(3) , 576-84, (2014) Dietary substances, including herbal products and citrus juices, can perpetrate interactions with conventional medications. Regulatory guidances for dietary substance-drug interaction assessment are l... |
Furocoumarin |
7H-Furo[3,2-g]chromen-7-one |
Psoralen |
EINECS 200-639-7 |
Psoralene |
prosuler |
6,7-Furanocoumarin |
MFCD00010520 |
Psorline-P |
FICUSIN |
7H-Furo[3,2-g][1]benzopyran-7-one |